Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months

Diagnostic Image Chronic obstructive pulmonary disease: A case report EDITORIAL Editorial Board The Good Nurse Success story of a patient with Haemangioma Role of physiotherapy in Bells Palsy at outpatient department Arrhythmogenic Right Ventricular Dysplasia: A Cardiomyopathy Systemic Lupus Erythematosus (SLE) Teamwork makes a Dreamwork Cholecysto Cutabeous Fistula, an emerging problem: a challenging outcome Adhesive small bowel obstruction: Nutrition care process Diagnostic Image: Moderate Pitting Edema in Lower Limbs Editorial Editorial Board Quality improvement project to reduce the incidence of ventilator-associated pneumonia Rare disease, desired outcome Management of patients with acute myocardial infarction with ischemic stroke Left mediastinal tumor excision Esophageal varices grade III: A case report TB meningitis: A case report Nutrition care process for Sigmoid Diverticulitis Nutritional management of patient who underwent emergency laparotomy and GIST Nutritional management of gestational diabetes mellitus Nutrition and drug interaction

Benefits of Sermorelin Peptide Sermorelin is most relevant when the primary goal is systemic growth hormone support rather than localized tissue repair
Severe kidney disease The gastrointestinal side effects of weight-loss injections (nausea, vomiting, diarrhoea) can cause dehydration, which can worsen existing kidney function
Every batch of CJC-1295 (No DAC) (5mg) + Ipamorelin (5mg) Research Bundle is tested for purity and identity using industry-standard methods
"We can choose to build on the foundation that peptides like BPC-157n have given us and find a responsible way forward - one where patients stay under a clinician's care, where that care is monitored and studied, and where we steadily get better at how we use these therapies in the service of human health," Anant Vinjamoori, Hims' chief medical officer, said at Thursday's meeting